Ang II–AT-1 receptor signaling promotes splenic monocyte motility and tissue emigration. (A) Percentage of monocytes lost from the spleen 1 day after MI or Ang II infusion in WT and Atgr1a−/− mice (means ± SEM, n= 4 to 9). (B) Serum Ang II concentrations in the steady-state (control), and 1 day after MI or infusion of Ang II (n = 6 to 9). (C) Total number of splenic monocytes (Ly-6Chigh and Ly-6Clow) in the groups of mice mentioned above. (D) Western blot analysis of monomeric and dimeric forms of the AT-1 receptor on control splenic monocytes in the steady state (control), and 1 day after MI or infusion of Ang II, n = 3. (E) In vitro migration of splenic monocytes in response to Ang II (1 µM) (means ± SEM, n = 6). (F) Intravital microscopy of GFP+ cells (green) in the spleen subcapsular red pulp of an Ang II–treated Cx3cr1gfp/+ mouse. Images show a splenic monocyte, an Mø or DC, and a patrolling monocyte. Blood is shown in red. Tracks indicate the position of cell centroids at 15-s intervals (time in min:s). (G) (Top) Intravital micrographs of GFP+ cells in control mice and 1 day after MI or infusion of Ang II at the initial recording time point. (Bottom) Tracks for all GFP+ cells in the field of view and over 1 hour. Some cells entered or exited our imaging area during the recording and thus were followed for a shorter duration. V, vessel; P, parenchyma. (H) Average displacement over time of all GFP+ splenic monocytes [means ± SEM, n = 143 (control), 163 (MI), and 125 (Ang II) cells]. (I) Displacement over time of single splenic monocytes (left), splenic macrophages of DCs (middle), and patrolling monocytes (right). (J) Recording of a departing splenic monocyte. Tracks indicate the position of the cell centroid. *P < 0.05, **P < 0.01, ***P < 0.001. Data pool two [(A) to (C), and (E)] or at least three independent experiments [(H) and (I)], or are from one experiment representative of at least three independent experiments [(D), (F), and (G)].